Also trades as: PREC.ST (STO) · $vol 0M
PRBCF OTC
Precise Biometrics AB (publ)
1W: +0.0%
1M: +0.0%
3M: -25.4%
YTD: -62.7%
1Y: -62.7%
3Y: -79.7%
5Y: -89.7%
$0.13
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$2M
-81.0% ▼
5Y CAGR: -38.5%
Capital Expenditures
$1M
+88.9% ▲
5Y CAGR: -41.1%
Free Cash Flow
$656K
+151.2% ▲
5Y CAGR: -30.3%
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+100.0% ▲
Net Change in Cash
-$13M
-31.4% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$14M | -$20M | -$26M | -$9M | -$20M |
| Depreciation & Amort. | $4M | $21M | $25M | $0 | $20M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$3M | $3M | -$10M | -$4M | $2M |
| Other Non-Cash Items | $11M | -$284K | $402K | $24M | -$452K |
| Operating Cash Flow | -$1M | $4M | -$11M | $10M | $2M |
| — Investing Activities — | |||||
| Capital Expenditures | -$20M | -$22M | -$1M | -$370K | -$13M |
| Acquisitions (Net) | -$11M | -$38M | -$10M | -$6M | -$6M |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | -$17M | -$21M | -$14M | -$11M | $0 |
| Investing Cash Flow | -$30M | -$60M | -$25M | -$18M | -$19M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | -$3M | $0 |
| Stock Repurchased | $0 | -$326K | $0 | -$3K | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$3M | -$6M | -$12M | $0 | -$2M |
| Financing Cash Flow | $20M | $38M | $37M | -$3M | -$2M |
| Net Change in Cash | -$12M | -$18M | $1M | -$10M | -$13M |
| Cash End of Period | $64M | $46M | $48M | $38M | $18M |
| Free Cash Flow | -$21M | -$18M | -$26M | -$1M | $656K |